Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Nature 579 , 598602 (2020)
The Phase 1 study (NCT04674306), conducted at Cleveland Clinics Main Campus in partnership with Anixa Biosciences, Inc., included 35 patients across three cohorts: Launched in 2021, the trial enrolled 26 patients in Phase 1a, four in Phase 1b, and five in Phase 1c
Thymus Overstimulation: TB-500 may potentially stimulate the thymus gland, which is responsible for immune system regulation
Melanotan-II reverses memory impairment induced by a short-term HF diet
Arn PH, Hauser ER, Thomas GH, Herman G, Hess D, Brusilow SW
Teaching NeuroImages: myelopathy due to B deficiency in long-term colchicine treatment and nitrous oxide misuse
US$ 20.50
US$ 24.22
US$ 21.65
US$ 27.73
US$ 22.12
US$ 22.00
US$ 28.30
US$ 23.64
US$ 21.28
US$ 23.58
